XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Capital Deficiency
3 Months Ended
Mar. 31, 2022
Capital Deficiency [Abstract]  
CAPITAL DEFICIENCY:

NOTE 9 – CAPITAL DEFICIENCY:

 

Share-based compensation

 

A summary of the Company’s share option activity under option plans is as follows:

 

     Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
 
  Outstanding – January 1, 2021   879,251   $0.0874    6.25 
  Granted   43,261   $1.3616      
  Exercised   2,763   $0.1058      
  Expired and forfeited   29,256   $0.0874      
                  
  Outstanding – December 31, 2021   890,493   $0.1518    5.43 
                  
  Exercisable – December 31, 2021   801,562   $0.276    5.10 

 

     Number of
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
 
  Outstanding – January 1, 2022   890,493   $0.1518    5.43 
  Granted   -   $-      
  Exercised   15,459   $0.0725      
  Expired and forfeited   1,862   $0.1058      
                  
  Outstanding – March 31, 2022   873,172   $0.1516    4.83 
                  
  Exercisable – March 31, 2022   799,692   $0.0917    5.13